This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (611) Glucose Tracking and Self-Monitoring of Blood Glucose (179) Diabetes Self-Management (526) Diabetes Health Services and System Innovations (129)

Published on in Vol 11, No 2 (2022): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33726, first published .
Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study)

Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study)

Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study)

Authors of this article:

Alexandria Ratzki-Leewing1 Author Orcid Image ;   Bridget L Ryan1, 2 Author Orcid Image ;   Guangyong Zou1, 3 Author Orcid Image ;   Susan Webster-Bogaert2 Author Orcid Image ;   Jason E Black2 Author Orcid Image ;   Kathryn Stirling2 Author Orcid Image ;   Kristina Timcevska2 Author Orcid Image ;   Nadia Khan2 Author Orcid Image ;   John D Buchenberger4 Author Orcid Image ;   Stewart B Harris1, 2 Author Orcid Image
Article Authors Cited by (4) Tweetations (5) Metrics

Journals

  1. Ratzki‐Leewing A, Black J, Ryan B, Harris S. Real‐world risk factors of confirmed or probable COVID‐19 in Americans with diabetes: A prospective, community‐based study (iNPHORM). Endocrinology, Diabetes & Metabolism 2022;5(4) View
  2. Black J, Harris S, Ryan B, Zou G, Ratzki-Leewing A. Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US). Diabetes Therapy 2023;14(8):1299 View
  3. Ratzki‐Leewing A, Black J, Ryan B, Zou G, Klar N, Webster‐Bogaert S, Timcevska K, Harris S. Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (theiNPHORMstudy, United States). Diabetes, Obesity and Metabolism 2023;25(10):2910 View
  4. Dhiman P, Ma J, Kirtley S, Mouka E, Waldron C, Whittle R, Collins G. Prediction model protocols indicate better adherence to recommended guidelines for study conduct and reporting. Journal of Clinical Epidemiology 2024;169:111287 View